Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Analysis of randomized controlled trial data shows non-Caucasian high-risk PCI patients significantly benefit from Impella-support

News | Intra-Aortic Balloon Pumps (IABP)

Abiomed Creates Patient Assistance Program to Address Disparities in Healthcare

October 26, 2022 — Abiomed (Nasdaq: ABMD) announces a new program to address healthcare disparities in underserved ...

October 26, 2022

Donald Baril, MD, a Leading Vascular Surgeon in the Smidt Heart Institute, Named Director of the Vascular Surgery Fellowship Program

News | Cardiovascular Surgery

Vascular Surgeon to Lead, Train Fellows

October 24, 2022 The Smidt Heart Institute at Cedars-Sinai has selected leading vascular surgeon Donald Baril, MD, as ...

October 24, 2022

News | Cardiovascular Business

Founder, Medical Co-Director of Preventive and Consultative Heart Center of Excellence at Smidt Heart Institute Remembered

October 24, 2022 — Asher Kimchi, MD, clinical chief of Cardiology, vice-clinical chief of the Department of Medicine ...

October 24, 2022

CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly selective, once daily, oral small molecule inhibitor of aldosterone synthase, in the journal Hypertension Research.

News | Hypertension

CinCor Pharma Announces Publication of Phase 1 Multiple Ascending Dose Study Data in Hypertension Research

October 24, 2022 — CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly ...

October 24, 2022

Abiomed announced the U.S. Food and Drug Administration (FDA) has accepted and closed the post-approval study reports related to the pre-market approvals (PMA) for Impella heart pumps.

News | Cardiogenic Shock

Abiomed Successfully Completes All Impella Post-Approval Studies for High-Risk PCI, Cardiogenic Shock, Post-Cardiotomy Cardiogenic Shock and Right Heart Failure

October 21, 2022 — Abiomed announced the U.S. Food and Drug Administration (FDA) has accepted and closed the post ...

October 21, 2022

The American Heart Association to enable a wide range of research with real-time data from acute care hospitals

News | Cardiogenic Shock

New Data Registry Collects Evidence in Cardiogenic Shock Patients

October 20, 2022 — Cardiogenic shock—a life threatening condition when a person’s heart can’t pump enough blood to meet ...

October 20, 2022

MedAtlas CV will transform cardiovascular care delivery and expand patient access

News | Cardiovascular Business

Atlas Healthcare Partners and MedAxiom Unveil Cardiovascular ASC Solution, MedAtlas CV

October 20, 2022 — Atlas Healthcare Partners – which specializes in developing and managing ambulatory surgery centers ...

October 20, 2022

After dedicating the last 28 years to building one of the world’s leading cardiovascular centers, Dr. Fuster will continue to advance the clinical care, research, and innovative training at Mount Sinai Heart. Image courtesy of Mount Sinai Health System

News | Cardiovascular Business

Valentin Fuster, MD, PhD, Named President of Mount Sinai Heart

October 19, 2022 — Mount Sinai Health System’s globally acclaimed cardiologist Valentin Fuster, MD, PhD, has been named ...

October 19, 2022

For men and women, the risk factors for cardiovascular disease are largely the same, an extensive global study involving University of Gothenburg researchers shows.

News | Heart Failure

Cardiovascular Disease Risks the Same in Both Sexes

October 19, 2022 — For men and women, the risk factors for cardiovascular disease are largely the same, an extensive ...

October 19, 2022

News | Heart Valve Technology

Foldax Appoints Gregory D. Casciaro as Chief Executive Officer

October 18, 2022 — Foldax, Inc. announced that medtech veteran Gregory D. Casciaro has been named Chief Executive ...

October 18, 2022

News | Heart Valve Technology

U.S. FDA Grants 510(k) Clearance for Impella Low Profile Sheath

October 18, 2022 — The United States Food and Drug Administration (FDA) has granted 510(k) clearance to Abiomed for its ...

October 18, 2022

People with cardiovascular disease still have a high burden of risk factors for severe COVID

News | Coronavirus (COVID-19)

Smoking, Diabetes and Obesity - Not Preexisting Heart Disease - Bigger Risk of COVID-19 Death, Study Finds

October 17, 2022 — A national study suggests that risk factors for cardiovascular disease, such as age, smoking and ...

October 17, 2022

Low-cost blood pressure lowering drugs, statins and aspirin widely in the form of a single pill, also known as the polypill. McMaster University

News | Pharmaceuticals

The Polypill Could Avoid Millions of Premature Deaths, Heart Attacks and Strokes Every Year, Say Leading Cardiology Experts

October 17, 2022 — Global Health has paid a deadly price for not using simple, low-cost blood pressure lowering drugs ...

October 17, 2022

Study data show clinically meaningful impact on quality of life and disease severity, even in the most complex patients

News | Venous Therapies

ABRE Clinical Study 36-Month Data Shows Sustained Effectiveness of Abre Venous Self-Expanding Stent System

October 14, 2022 — Medtronic, a global leader in medical technology, announced the 36-month final results from the ABRE ...

October 14, 2022

Heart Initiative, the sponsor of the STRONG-HF (Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP testinG, of Heart Failure therapies) study, announced the premature termination of the trial.

News | Cardiovascular Clinical Studies

STRONG-HF Study in Patients Admitted for Acute Heart Failure (HF) Terminated Early for Superior Efficacy

October 14, 2022 — Heart Initiative, the sponsor of the STRONG-HF (Safety, Tolerability and efficacy of Rapid ...

October 14, 2022